Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
22.50
-0.47 (-2.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Phibro Animal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 1,106 | 1,018 | 977.89 | 942.26 | 833.35 | 800.35 | Upgrade
|
| Revenue Growth (YoY) | 12.63% | 4.07% | 3.78% | 13.07% | 4.12% | -3.34% | Upgrade
|
| Cost of Revenue | 752.12 | 704.07 | 679.65 | 656.55 | 561.97 | 543.19 | Upgrade
|
| Gross Profit | 353.96 | 313.61 | 298.24 | 285.72 | 271.38 | 257.16 | Upgrade
|
| Selling, General & Admin | 216.42 | 217.89 | 192.06 | 183.53 | 193.82 | 189.62 | Upgrade
|
| Research & Development | 29.19 | 29.19 | 24.4 | 20.83 | - | - | Upgrade
|
| Other Operating Expenses | 4.2 | 4.2 | 6.89 | - | - | - | Upgrade
|
| Operating Expenses | 252.8 | 254.27 | 226.39 | 207.34 | 196.51 | 189.62 | Upgrade
|
| Operating Income | 101.16 | 59.34 | 71.85 | 78.38 | 74.87 | 67.54 | Upgrade
|
| Interest Expense | -30.19 | -23.01 | -18.68 | -12.69 | -12.7 | -14.61 | Upgrade
|
| Interest & Investment Income | 4.24 | 4.47 | 3.36 | 0.82 | 0.84 | 1.76 | Upgrade
|
| Currency Exchange Gain (Loss) | -21.83 | -23.86 | -2.46 | 5.22 | 4.48 | -0.83 | Upgrade
|
| EBT Excluding Unusual Items | 53.38 | 16.94 | 54.07 | 71.72 | 67.49 | 53.86 | Upgrade
|
| Merger & Restructuring Charges | -20.49 | -6.93 | - | -0.6 | - | -1.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 1.2 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -1.02 | 2.82 | Upgrade
|
| Pretax Income | 33.79 | 10.92 | 54.07 | 72.33 | 66.47 | 55.51 | Upgrade
|
| Income Tax Expense | 14.47 | 8.5 | 21.47 | 23.15 | 12.08 | 21.96 | Upgrade
|
| Net Income | 19.32 | 2.42 | 32.61 | 49.18 | 54.39 | 33.55 | Upgrade
|
| Net Income to Common | 19.32 | 2.42 | 32.61 | 49.18 | 54.39 | 33.55 | Upgrade
|
| Net Income Growth | 30.53% | -92.59% | -33.69% | -9.58% | 62.09% | -38.68% | Upgrade
|
| Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 40 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 41 | 41 | 41 | 41 | 41 | Upgrade
|
| Shares Change (YoY) | 0.23% | 0.05% | - | - | - | -0.05% | Upgrade
|
| EPS (Basic) | 0.48 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | Upgrade
|
| EPS (Diluted) | 0.48 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | Upgrade
|
| EPS Growth | 30.53% | -92.59% | -33.47% | -9.70% | 61.57% | -38.56% | Upgrade
|
| Free Cash Flow | 15.33 | 46.36 | -38.48 | -5.4 | 18.99 | 25.3 | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 1.14 | -0.95 | -0.13 | 0.47 | 0.62 | Upgrade
|
| Dividend Per Share | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | 0.480 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 0% | 0% | 4.35% | Upgrade
|
| Gross Margin | 32.00% | 30.82% | 30.50% | 30.32% | 32.56% | 32.13% | Upgrade
|
| Operating Margin | 9.15% | 5.83% | 7.35% | 8.32% | 8.98% | 8.44% | Upgrade
|
| Profit Margin | 1.75% | 0.24% | 3.33% | 5.22% | 6.53% | 4.19% | Upgrade
|
| Free Cash Flow Margin | 1.39% | 4.56% | -3.94% | -0.57% | 2.28% | 3.16% | Upgrade
|
| EBITDA | 138.7 | 94.08 | 104.4 | 110.04 | 105.5 | 98.84 | Upgrade
|
| EBITDA Margin | 12.54% | 9.24% | 10.68% | 11.68% | 12.66% | 12.35% | Upgrade
|
| D&A For EBITDA | 37.54 | 34.74 | 32.56 | 31.66 | 30.63 | 31.3 | Upgrade
|
| EBIT | 101.16 | 59.34 | 71.85 | 78.38 | 74.87 | 67.54 | Upgrade
|
| EBIT Margin | 9.15% | 5.83% | 7.35% | 8.32% | 8.98% | 8.44% | Upgrade
|
| Effective Tax Rate | 42.83% | 77.87% | 39.70% | 32.01% | 18.18% | 39.56% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.